Status:
COMPLETED
Babesia Testing in Blood Donors
Lead Sponsor:
Imugen
Collaborating Sponsors:
American National Red Cross
Memorial Blood Centers, Minnesota
Conditions:
Transfusion Transmitted Babesiosis
Eligibility:
All Genders
16+ years
Phase:
PHASE3
Brief Summary
Both prospective and retrospective (look back) study of blood donors for laboratory evidence of babesia microti infection. Two laboratory methodologies will be utilized: 1. \- PCR, to look for the p...
Detailed Description
Retrospective study will involve archived specimens from blood donors whose units have already been released and transfused into recipients. Prospective study will be real time and units testing posi...
Eligibility Criteria
Inclusion
- same as for donating blood
Exclusion
- donor refusual to sign informed consent for this investigational babesia testing
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
90116 Patients enrolled
Trial Details
Trial ID
NCT01528449
Start Date
December 1 2011
End Date
September 1 2014
Last Update
September 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imugen
Norwood, Massachusetts, United States, 02062